For investors
Early, and building in the open.
A plain note. Not a fundraising page.
What we offer
The app
Trading-record diagnosis. ₹299 a month or ₹2,499 a year after early access ($9 / $79 outside India).
For platforms
The same diagnosis, by API.
Books and videos
The ideas behind the numbers.
Where we are
- Web app liveIndia and US brokers
- Android in testingGoogle Play
- Early accessFree for everyone
- Paid checkoutAfter early access
The obvious risks
One person
Key-person risk until the team grows.
No revenue yet
Checkout is closed during early access.
Regulation
Descriptive only. Anything that needs a licence waits for one.